The Next Step in the Opioid Epidemic: Protecting Government-Sponsored Health Plans from...

The misuse and abuse of opioids continues to be an epidemic in this country. As efforts are made to identify and...

Read More

Incentivizing Specialty Generics Can Save Both Plan Sponsors and Members Thousands

Specialty medications continue to be a predominant topic in the healthcare industry, as more and more of these novel...

Read More

Needed Relief for Hard-to-Treat Skin Condition: New Treatment Options in the Drug Pipeline for...

Atopic dermatitis (AD) is a skin condition that affects approximately 9.6 million children in the United States, with...

Read More

Aiming for Better Medication Adherence Leads to a Trifecta of Improvements: Better Healthcare,...

According to the World Health Organization (WHO), approximately 50% of people with chronic conditions do not take their...

Read More

Adding Value to Pharmacy Benefit Management Through Lean Principles

It is estimated that service industries, such as health and pharmacy benefits, spend 30% to 80% in added costs from...

Read More

Three Steps to Improving Member Health and Controlling Costs

According to the Centers for Disease Control and Prevention (CDC), six in 10 U.S. adults have a chronic disease and...

Read More

Bringing Some Clarity to 2022: The Centers for Medicare and Medicaid Services (CMS) Releases the...

The year 2020 was unprecedented in many ways and that included the CMS rulemaking process for contract year 2021...

Read More

The Path Back to Normal: Your Questions Answered About COVID-19 Vaccinations

The COVID-19 pandemic has had worldwide impact on our daily lives, creating a new “normal” for most of us. In December...

Read More

Formularies Don't Have to Equal Dissatisfaction: A Balanced Approach is the Solution

According to a recent study in the Journal of the American Medical Association, prescription drug prices increased 3.5...

Read More

News on Approval of the First Oral Preventive Therapy for Hereditary Angioedema and More

From development of the first treatment for Niemann-Pick disease to approval of a medication that reduces the risk of...

Read More